The majority of RNAs in each of our cells don't code for any of the thousands of proteins that make up our bodies. Instead, ...

We used cDNA microarrays to explore the variation in expression of approximately 8,000 unique genes among the 60 cell lines used in the National Cancer Institute's screen for anti-cancer drugs.

Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

Q1 2025 Earnings Conference Call May 9, 2025 10:00 AM ETCompany ParticipantsJustine Koenigsberg - Vice President ...

In this work, we proposed a novel drug synergy prediction model called GraphTranSynergy, which utilized graph transformer and BiLSTM to capture the molecular structure of drugs and gene expression ...

Immune system scientists and computational biologists are developing a new tool to investigate how the body fights disease.

The research team introduced two key quantitative concepts - the transcriptional threshold  and jumping index  - to establish ...

engineers have designed a new control circuit that can keep gene expression levels within a target range. The method could be used to deliver genes that could help treat diseases including ...

Researchers use generative AI to design synthetic enhancers that can effectively control gene expression in healthy mammalian cells.

This study exploring the role of TRPV1 signaling in recruiting macrophages and promoting angiogenesis during tympanic membrane wound healing presents useful findings. However, the strength of evidence ...